Submitted by Jeffrey Lake on Wed, 05/06/2015 - 12:13pm Using the scale below, please rate this CME activity. * Very PoorPoorNeutralGoodExcellent Overall Evaluation Overall Evaluation - Very Poor Overall Evaluation - Poor Overall Evaluation - Neutral Overall Evaluation - Good Overall Evaluation - Excellent Content Content - Very Poor Content - Poor Content - Neutral Content - Good Content - Excellent Usefulness Usefulness - Very Poor Usefulness - Poor Usefulness - Neutral Usefulness - Good Usefulness - Excellent Quality Quality - Very Poor Quality - Poor Quality - Neutral Quality - Good Quality - Excellent As a result of this activity, I am able to: * YesNo Review the pathophysiology of asthma and symptoms associated with disease progression. Review the pathophysiology of asthma and symptoms associated with disease progression. - Yes Review the pathophysiology of asthma and symptoms associated with disease progression. - No Examine the mechanism of action of targeted biologic therapies, and analyze their role in asthma treatment, including within special patient populations. Examine the mechanism of action of targeted biologic therapies, and analyze their role in asthma treatment, including within special patient populations. - Yes Examine the mechanism of action of targeted biologic therapies, and analyze their role in asthma treatment, including within special patient populations. - No Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes in asthma management. Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes in asthma management. - Yes Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes in asthma management. - No How many patients do you see with asthma each month? * - Select -01-1011-2021-3031-4041-5051-60>60N/A: I don’t see any patients After participating in this activity, how confident are you in your ability to: * On a scale of 1 to 5, with 1 meaning NOT at all confident and 5 meaning EXTREMELY confident. 12345 Identify asthma symptoms associated with disease progression? Identify asthma symptoms associated with disease progression? - 1 Identify asthma symptoms associated with disease progression? - 2 Identify asthma symptoms associated with disease progression? - 3 Identify asthma symptoms associated with disease progression? - 4 Identify asthma symptoms associated with disease progression? - 5 Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? - 1 Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? - 2 Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? - 3 Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? - 4 Integrate patient communication and education strategies into personalized treatment plans in order to optimize outcomes? - 5 As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with asthma. * Yes No Please take a moment to reflect on your PLANNED use of the following practice strategies discussed in this activity. You will not be graded on your responses. * Using the below scale, please indicate how often you NOW PLAN to use the each of the following clinical practice strategies for your patients with asthma. Clinical Practice Strategies Your Planned Use: 1 - Never for me 2 - Not often 3 - Sometimes 4 - Often 5 - Always 6 - N/A 123456 Utilize appropriate biomarkers when developing personalized treatment plans Utilize appropriate biomarkers when developing personalized treatment plans - 1 Utilize appropriate biomarkers when developing personalized treatment plans - 2 Utilize appropriate biomarkers when developing personalized treatment plans - 3 Utilize appropriate biomarkers when developing personalized treatment plans - 4 Utilize appropriate biomarkers when developing personalized treatment plans - 5 Utilize appropriate biomarkers when developing personalized treatment plans - 6 Apply appropriate biologic therapies in special patient populations Apply appropriate biologic therapies in special patient populations - 1 Apply appropriate biologic therapies in special patient populations - 2 Apply appropriate biologic therapies in special patient populations - 3 Apply appropriate biologic therapies in special patient populations - 4 Apply appropriate biologic therapies in special patient populations - 5 Apply appropriate biologic therapies in special patient populations - 6 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 1 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 2 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 3 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 4 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 5 Develop a clinician/patient partnership in order to ensure adherence to asthma treatments - 6 Do you feel the activity was fair balanced and free of commercial bias? * Yes No If no, please explain. What topics would you like to see in future CME activities? Do you wish to be notified by email when new educational programs are offered by Elsevier? Yes No Leave this field blank
